Share this story
The multi-district litigation surrounding Bard PowerPort implanted port catheter devices has expanded significantly across federal court dockets, centering on allegations that polyurethane catheter tubing formulations experienced premature degradation, fracture, and vascular migration.
Federal presiding judges have established bellwether trial schedules to test core legal theories regarding manufacturing disclosure, biocompatibility testing standards, and failure-to-warn doctrines.
“Modern reporting requires not just speed, but the depth to analyze how rapid technological and cultural shifts reshape community resilience.”— ApexChief Editorial Board
